Acute Respiratory Distress Syndrome News

Acute Respiratory Distress Syndrome	Welcome, Profile Billing Logout

12 3 4 5 6 7 8 9 10 11 12 13...15 16 »

||||||||||  betamethasone / Generic mfg.
Trial completion, Trial completion date:  Betamethasone and Severity of Hyaline Membrane Disease (clinicaltrials.gov) -  Apr 20, 2019
P=N/A, N=127, Completed,  Sponsor: Assistance Publique - H
Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2018

||||||||||  NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date:  CLEAR: Clinical Application of Electrical Impedance Tomography for Individual Adjustment of Ventilator Settings (clinicaltrials.gov) -  Apr 19, 2019
P=N/A, N=20, Completed,  Sponsor: University of Schleswig-Holstein
Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2018 Recruiting --> Completed | Trial completion date: Dec 2018 --> Apr 2019 | Trial primary completion date: Jun 2018 --> Apr 2019

|||||||||| Trial completion, Trial completion date, Trial primary completion date: FEDOX: Feeding the Critically Ill During Phases of Altered Redox Status (clinicaltrials.gov) - Apr 16, 2019
P=N/A, N=35, Completed, Sponsor: University of Illinois at Chicago
Recruiting --> Completed | Trial completion date: Dec 2018 --> Apr 2019 | Trial primary completion date: Jun 2018 --> Apr 2019 Recruiting --> Completed | Trial completion date: Dec 2019 --> Oct 2018 | Trial primary completion date: Sep 2019 --> Jun 2018

|||||||||| Enrollment change, Trial termination: BIRRST: Breastfeeding Infants Receiving Respiratory Support Trial (clinicaltrials.gov) - Apr 11, 2019
P=N/A, N=1, Terminated, Sponsor: Imperial College Healthcare NHS Trust
Recruiting --> Completed | Trial completion date: Dec 2019 --> Oct 2018 | Trial primary completion date: Sep 2019 --> Jun 2018 N=50 --> 1 | Recruiting --> Terminated; Failure to recruit participants due to change in local clinical practice.

||||||||||  NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date:  USEFUL: Ultrasound to Evaluate Failure of Liberation From Mechanical Ventilation (clinicaltrials.gov) -  Mar 28, 2019
P=N/A, N=7, Completed,  Sponsor: University Health Network, Toronto
N=50 --> 1 | Recruiting --> Terminated; Failure to recruit participants due to change in local clinical practice. Recruiting --> Completed | N=50 --> 7 | Trial completion date: Jun 2019 --> Dec 2018

||||||||||  Leukine (sargramostim) / Partner Therap
Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date:  iGRASP: Inhaled GM-CSF for Respiratory Virus-Associated Severe Pneumonia (clinicaltrials.gov) -  Mar 26, 2019
P1, N=0, Withdrawn,  Sponsor: Milton S. Hershey Medical Center
Recruiting --> Completed | N=50 --> 7 | Trial completion date: Jun 2019 --> Dec 2018 N=12 --> 0 | Trial completion date: Dec 2017 --> May 2019 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2017 --> May 2019

|||||||||| Trial completion, Trial completion date, Trial primary completion date: CRADL: Continuous Regional Analysis Device for Neonate Lung (clinicaltrials.gov) - Mar 21, 2019
P=N/A, N=200, Completed, Sponsor: University of Schleswig-Holstein
N=12 --> 0 | Trial completion date: Dec 2017 --> May 2019 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2017 --> May 2019 Recruiting --> Completed | Trial completion date: Dec 2019 --> Mar 2019 | Trial primary completion date: Dec 2018 --> Mar 2019

||||||||||  atibuclimab (IC14) / Implicit Biosci
Enrollment change, Trial withdrawal:  A Phase 2 Study of IC14 in Acute Respiratory Distress Syndrome (clinicaltrials.gov) -  Mar 14, 2019
P2, N=0, Withdrawn,  Sponsor: Implicit Bioscience
Recruiting --> Completed | Trial completion date: Dec 2019 --> Mar 2019 | Trial primary completion date: Dec 2018 --> Mar 2019 N=160 --> 0 | Not yet recruiting --> Withdrawn

||||||||||  aspirin / Generic mfg.
Trial completion date, Trial termination, Trial primary completion date:  ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial (clinicaltrials.gov) -  Mar 13, 2019
P2, N=49, Terminated,  Sponsor: Belfast Health and Social Care Trust
N=160 --> 0 | Not yet recruiting --> Withdrawn Trial completion date: Jul 2017 --> Nov 2018 | Enrolling by invitation --> Terminated | Trial primary completion date: Jul 2017 --> Nov 2018; Slow recruitment

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Pilot Study on Pairing Sedation Strategies and Weaning (clinicaltrials.gov) -  Mar 13, 2019
P=N/A, N=90, Completed,  Sponsor: MemorialCare Health System
Trial completion date: Jul 2017 --> Nov 2018 | Enrolling by invitation --> Terminated | Trial primary completion date: Jul 2017 --> Nov 2018; Slow recruitment Recruiting --> Completed

|||||||||| Trial completion, Trial completion date, Trial primary completion date: HIGH-WEAN: High-flow Nasal Cannula Oxygen Therapy With or Without NIV During the Weaning Period (clinicaltrials.gov) - Mar 13, 2019
P=N/A, N=650, Completed, Sponsor: Poitiers University Hospital
Recruiting --> Completed Recruiting --> Completed | Trial completion date: Apr 2020 --> Apr 2018 | Trial primary completion date: Apr 2020 --> Apr 2018

||||||||||  InfaSurf (calfactant) / Samaritan Pharma, Ony Biotech, AbbVie
Trial completion:  Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients (clinicaltrials.gov) -  Mar 13, 2019
P3, N=477, Completed,  Sponsor: ONY
Recruiting --> Completed | Trial completion date: Apr 2020 --> Apr 2018 | Trial primary completion date: Apr 2020 --> Apr 2018 Active, not recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion, Trial completion date:  The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome (clinicaltrials.gov) -  Feb 28, 2019
P=N/A, N=160, Completed,  Sponsor: Indiana University
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2017

||||||||||  NN1213 / Novo Nordisk
Trial completion date:  The Role of IL33/ST2 Axis in ARDS Patients (clinicaltrials.gov) -  Feb 26, 2019
P=N/A, N=200, Completed,  Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2017 Trial completion date: Dec 2017 --> Dec 2019

||||||||||  dexamethasone injection / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date:  DEXA-ARDS: Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome (clinicaltrials.gov) -  Feb 18, 2019
P4, N=277, Completed,  Sponsor: Dr. Negrin University Hospital
Trial completion date: Dec 2017 --> Dec 2019 Recruiting --> Completed | Trial completion date: Oct 2018 --> Feb 2019 | Trial primary completion date: Oct 2018 --> Feb 2019

||||||||||  Curosurf (poractant alfa) / Chiesi, NN1213 / Novo Nordisk
Trial completion, Trial primary completion date:  Efficacy of a New Technique -"IN-REC-SUR-E"- in Preterm Neonates With RDS (clinicaltrials.gov) -  Feb 15, 2019
P=N/A, N=206, Completed,  Sponsor: Catholic University of the Sacred Heart
Recruiting --> Completed | Trial completion date: Oct 2018 --> Feb 2019 | Trial primary completion date: Oct 2018 --> Feb 2019 Recruiting --> Completed | Trial primary completion date: Dec 2018 --> Sep 2018

|||||||||| Trial completion, Enrollment change: Nasal High Frequency Oscillation Ventilation(NHFOV) for Respiratory Distress Syndrome (clinicaltrials.gov) - Feb 15, 2019
P=N/A, N=206, Completed, Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Recruiting --> Completed | Trial primary completion date: Dec 2018 --> Sep 2018 Recruiting --> Completed | N=100 --> 206

|||||||||| Enrollment change, Trial withdrawal: Autologous Umbilical Cord Blood Transfusion for Preterm Neonates (clinicaltrials.gov) - Feb 12, 2019
P1, N=0, Withdrawn, Sponsor: Sahar M.A. Hassanein, MD
Recruiting --> Completed | N=100 --> 206 N=60 --> 0 | Recruiting --> Withdrawn

||||||||||  NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  Prevention of Severe Acute Respiratory Failure in Patients With PROOFCheck (clinicaltrials.gov) -  Feb 8, 2019
P=N/A, N=34040, Completed,  Sponsor: Albert Einstein College of Medicine
N=60 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed | N=3459 --> 34040 | Trial completion date: Jul 2019 --> Sep 2018 | Trial primary completion date: Jan 2019 --> Sep 2018

||||||||||  NN1213 / Novo Nordisk
Trial completion:  The Role of IL33/ST2 Axis in ARDS Patients (clinicaltrials.gov) -  Jan 25, 2019
P=N/A, N=200, Completed,  Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Recruiting --> Completed | N=3459 --> 34040 | Trial completion date: Jul 2019 --> Sep 2018 | Trial primary completion date: Jan 2019 --> Sep 2018 Recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  pEsition: Position and Esophageal Pressure (clinicaltrials.gov) -  Jan 22, 2019
P=N/A, N=11, Completed,  Sponsor: Hospices Civils de Lyon
Recruiting --> Completed Recruiting --> Completed | N=34 --> 11 | Trial completion date: May 2018 --> Sep 2017 | Trial primary completion date: May 2018 --> Sep 2017

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Work of Breathing During Non-invasive Ventilation in Premature Neonates (clinicaltrials.gov) -  Jan 11, 2019
P=N/A, N=15, Completed,  Sponsor: Arkansas Children's Hospital Research Institute
Recruiting --> Completed | N=34 --> 11 | Trial completion date: May 2018 --> Sep 2017 | Trial primary completion date: May 2018 --> Sep 2017 Recruiting --> Completed

|||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Clinical Trial of Nebulized Hypertonic Saline to Attenuate Post-Traumatic Acute Lung Injury (clinicaltrials.gov) - Dec 20, 2018
P1, N=13, Terminated, Sponsor: Denver Health and Hospital Authority
Recruiting --> Completed N=20 --> 13 | Trial completion date: May 2021 --> Nov 2018 | Recruiting --> Terminated | Trial primary completion date: May 2021 --> Nov 2018; low enrollment and loss of funding

||||||||||  NN1213 / Novo Nordisk
Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  Lung and Systemic Inflammation in the Critically Ill Patient (clinicaltrials.gov) -  Dec 11, 2018
P=N/A, N=8, Terminated,  Sponsor: Rigshospitalet, Denmark
N=20 --> 13 | Trial completion date: May 2021 --> Nov 2018 | Recruiting --> Terminated | Trial primary completion date: May 2021 --> Nov 2018; low enrollment and loss of funding N=18 --> 8 | Trial completion date: Nov 2017 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Nov 2016 --> Dec 2018; Slow enrollment and therefore not possible to reach the estimated enrollment

|||||||||| Trial termination: Open Lung Ventilation in ARDS: The PHARLAP Trial (clinicaltrials.gov) - Nov 28, 2018
P=N/A, N=115, Terminated, Sponsor: Australian and New Zealand Intensive Care Research Centre
N=18 --> 8 | Trial completion date: Nov 2017 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Nov 2016 --> Dec 2018; Slow enrollment and therefore not possible to reach the estimated enrollment Active, not recruiting --> Terminated; Halted by the Management Committee after the publication of the ART Trial

|||||||||| Trial primary completion date: Early Use of Noninvasive Positive Pressure Ventilation for Intro-pulmonary Acute Lung Injury (clinicaltrials.gov) - Nov 21, 2018
P=N/A, N=204, Completed, Sponsor: Beijing Hospital
Active, not recruiting --> Terminated; Halted by the Management Committee after the publication of the ART Trial Trial primary completion date: Jun 2013 --> Dec 2016

|||||||||| Enrollment change, Trial primary completion date: Noninvasive Positive Pressure Ventilation in Moderate Acute Respiratory Distress Syndrome (clinicaltrials.gov) - Nov 21, 2018
P=N/A, N=120, Completed, Sponsor: Beijing Hospital
Trial primary completion date: Jun 2013 --> Dec 2016 N=200 --> 120 | Trial primary completion date: Jul 2013 --> Dec 2016

||||||||||  NN1213 / Novo Nordisk
Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date:  Anti-MERS-CoV Convalescent Plasma Therapy (clinicaltrials.gov) -  Nov 21, 2018
P2, N=0, Withdrawn,  Sponsor: King Abdullah International Medical Research Center
N=200 --> 120 | Trial primary completion date: Jul 2013 --> Dec 2016 N=20 --> 0 | Trial completion date: Jun 2017 --> Nov 2016 | Active, not recruiting --> Withdrawn | Trial primary completion date: May 2017 --> May 2016

||||||||||  NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial initiation date:  Evaluation of the Diagnostic Performance of Electrical Impedance Tomography to Detect Situations at Risk of Lesions Induced by Conventional Mechanical Ventilation in ARDS (clinicaltrials.gov) -  Nov 15, 2018
P=N/A, N=3, Completed,  Sponsor: Hospices Civils de Lyon
N=20 --> 0 | Trial completion date: Jun 2017 --> Nov 2016 | Active, not recruiting --> Withdrawn | Trial primary completion date: May 2017 --> May 2016 Recruiting --> Completed | N=10 --> 3 | Initiation date: Jun 2011 --> Jul 2012

||||||||||  NN1213 / Novo Nordisk
Enrollment change:  STANDARDS: Stratification of the Acute Respiratory Distress Syndrome (clinicaltrials.gov) -  Oct 12, 2018
P=N/A, N=300, Completed,  Sponsor: Dr. Negrin University Hospital
Recruiting --> Completed | N=10 --> 3 | Initiation date: Jun 2011 --> Jul 2012 N=600 --> 300

||||||||||  NN1213 / Novo Nordisk
Trial completion, Enrollment change:  Esophageal Manometry in Mechanically Ventilated Patients (clinicaltrials.gov) -  Oct 11, 2018
P=N/A, N=20, Completed,  Sponsor: Sahlgrenska University Hospital, Sweden
N=600 --> 300 Recruiting --> Completed | N=40 --> 20

||||||||||  Curosurf (poractant alfa) / Chiesi, NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date:  Efficacy of a New Technique -"IN-REC-SUR-E"- in Preterm Neonates With RDS (clinicaltrials.gov) -  Sep 4, 2018
P=N/A, N=206, Recruiting,  Sponsor: Catholic University of the Sacred Heart
Recruiting --> Completed | N=40 --> 20 Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Dec 2018

|||||||||| Phase classification: Effect of Supine or Prone Position After Caesarean Birth (clinicaltrials.gov) - Aug 31, 2018
P=N/A, N=65, Completed, Sponsor: Montefiore Medical Center
Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Dec 2018 Phase classification: P1 --> P=N/A

|||||||||| Phase classification: Effect Of Acute Inflammatory Mediators On Functional Limitations In Patients With Acute Respiratory Failure (clinicaltrials.gov) - Aug 15, 2018
P=N/A, N=100, Completed, Sponsor: Wake Forest University
Phase classification: P1 --> P=N/A Phase classification: P1/2 --> P=N/A

||||||||||  dexamethasone injection / Generic mfg.
Trial completion date, Trial primary completion date:  DEXA-ARDS: Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome (clinicaltrials.gov) -  Aug 1, 2018
P4, N=314, Recruiting,  Sponsor: Dr. Negrin University Hospital
Phase classification: P1/2 --> P=N/A Trial completion date: Jun 2018 --> Oct 2018 | Trial primary completion date: Jun 2018 --> Oct 2018

|||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: ViPS: Variable Pressure Support Trial (clinicaltrials.gov) - Jul 26, 2018
P=N/A, N=130, Terminated, Sponsor: Technische Universit
Trial completion date: Jun 2018 --> Oct 2018 | Trial primary completion date: Jun 2018 --> Oct 2018 N=228 --> 130 | Trial completion date: Aug 2017 --> Jan 2018 | Recruiting --> Terminated | Trial primary completion date: Aug 2017 --> Jan 2018; Rate of recruitment

||||||||||  NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date:  A Randomised Controlled Trial of High-Flow Nasal Oxygen Versus Standard Oxygen Therapy in Critically Ill Immunocompromised Patients (clinicaltrials.gov) -  Jul 24, 2018
P=N/A, N=776, Completed,  Sponsor: Assistance Publique - H
N=228 --> 130 | Trial completion date: Aug 2017 --> Jan 2018 | Recruiting --> Terminated | Trial primary completion date: Aug 2017 --> Jan 2018; Rate of recruitment Recruiting --> Completed | Trial completion date: Dec 2018 --> Dec 2017 | Trial primary completion date: May 2018 --> Dec 2017

||||||||||  NN1213 / Novo Nordisk
Trial completion:  Ultra Protective Ventilation Without Extracorporeal Circulation in Severe ARDS Patients (VT4ARDS) (clinicaltrials.gov) -  Jul 20, 2018
P=N/A, N=37, Completed,  Sponsor: Hospices Civils de Lyon
Recruiting --> Completed | Trial completion date: Dec 2018 --> Dec 2017 | Trial primary completion date: May 2018 --> Dec 2017 Active, not recruiting --> Completed

||||||||||  NN1213 / Novo Nordisk
Trial completion:  The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients (clinicaltrials.gov) -  Jul 18, 2018
P=N/A, N=10, Completed,  Sponsor: Yonsei University
Active, not recruiting --> Completed Recruiting --> Completed

|||||||||| Phase classification: Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure (clinicaltrials.gov) - Jul 3, 2018
P=N/A, N=60, Completed, Sponsor: Tufts Medical Center
Recruiting --> Completed Phase classification: P4 --> P=N/A

||||||||||  InfaSurf (calfactant) / Samaritan Pharma, Ony Biotech, AbbVie
Enrollment closed, Trial completion date, Trial primary completion date:  Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients (clinicaltrials.gov) -  Jun 28, 2018
P3, N=477, Active, not recruiting,  Sponsor: ONY
Phase classification: P4 --> P=N/A Recruiting --> Active, not recruiting | Trial completion date: Dec 2018 --> Jul 2018 | Trial primary completion date: Dec 2018 --> Jun 2018

||||||||||  NN1213 / Novo Nordisk
Enrollment change, Trial termination, Trial primary completion date:  Stress Index to Individualize Mechanical Ventilation in ARDS (clinicaltrials.gov) -  Jun 7, 2018
P=N/A, N=4, Terminated,  Sponsor: Vanderbilt University
Recruiting --> Active, not recruiting | Trial completion date: Dec 2018 --> Jul 2018 | Trial primary completion date: Dec 2018 --> Jun 2018 N=10 --> 4 | Recruiting --> Terminated | Trial primary completion date: Jun 2018 --> Dec 2017; The ART Trial was published suggesting harm by the intervention protocol, which was closely related to the protocol in this study, so the study was terminated.

||||||||||  NN1213 / Novo Nordisk
Trial completion, Stroma:  Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START) (clinicaltrials.gov) -  May 3, 2018
P2, N=60, Completed,  Sponsor: Michael A. Matthay
N=10 --> 4 | Recruiting --> Terminated | Trial primary completion date: Jun 2018 --> Dec 2017; The ART Trial was published suggesting harm by the intervention protocol, which was closely related to the protocol in this study, so the study was terminated. Active, not recruiting --> Completed

|||||||||| Enrollment closed, Trial completion date, Trial primary completion date: Ultra Protective Ventilation Without Extracorporeal Circulation in Severe ARDS Patients (VT4ARDS) (clinicaltrials.gov) - Apr 13, 2018
P=N/A, N=37, Active, not recruiting, Sponsor: Hospices Civils de Lyon
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial completion date: Jan 2020 --> Jun 2018 | Trial primary completion date: Jan 2020 --> Jun 2018

|||||||||| Trial completion, Trial completion date, Trial primary completion date: Validation of a Simple Approach to Estimate Alveolar Recruitability in ARDS Patients (clinicaltrials.gov) - Apr 12, 2018
P=N/A, N=45, Completed, Sponsor: St. Michael's Hospital, Toronto
Recruiting --> Active, not recruiting | Trial completion date: Jan 2020 --> Jun 2018 | Trial primary completion date: Jan 2020 --> Jun 2018 Recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2017 | Trial primary completion date: Jun 2018 --> Dec 2017

|||||||||| Trial completion, Phase classification: Proper Pressure and Duration of Sustained Lung Inflation in Preterm Infants (clinicaltrials.gov) - Apr 3, 2018
P1, N=100, Completed, Sponsor: Mansoura University Children Hospital
Recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2017 | Trial primary completion date: Jun 2018 --> Dec 2017 Recruiting --> Completed | Phase classification: PN/A --> P1

|||||||||| Enrollment change, Trial termination: Cardiopulmonary Effects of Bronchoalveolar Wash on Patients With Acute Respiratory Distress Syndrome (clinicaltrials.gov) - Mar 30, 2018
P=N/A, N=24, Terminated, Sponsor: University Hospital, Limoges
Recruiting --> Completed | Phase classification: PN/A --> P1 N=50 --> 24 | Recruiting --> Terminated; Not enough patient

||||||||||  dexmedetomidine / Generic mfg.
Enrollment change:  Testing the Feasibility of Patient Controlled Sedation for Ventilated ICU Patients (clinicaltrials.gov) -  Mar 13, 2018
P1/2, N=15, Completed,  Sponsor: University of Minnesota - Clinical and Translational Science Institute
N=50 --> 24 | Recruiting --> Terminated; Not enough patient N=38 --> 15

|||||||||| Phase classification, Enrollment change, Trial completion date, Trial termination, Trial primary completion date: PROVAP: Enhanced Lung Protective Ventilation for ARDS Patients With PrismaLung (clinicaltrials.gov) - Mar 13, 2018
P=N/A, N=1, Terminated, Sponsor: H
N=38 --> 15 Phase classification: P3 --> P=N/A | N=14 --> 1 | Trial completion date: May 2019 --> Dec 2017 | Not yet recruiting --> Terminated | Trial primary completion date: Sep 2018 --> Oct 2017; Insufficient CO2 removal obtained with the PrismaLung membrane oxygenator

|||||||||| Trial completion, Enrollment change: APRONET: Prevalence of Prone Positioning Use in ARDS Patients (clinicaltrials.gov) - Mar 12, 2018
P=N/A, N=736, Completed, Sponsor: Hospices Civils de Lyon
Phase classification: P3 --> P=N/A | N=14 --> 1 | Trial completion date: May 2019 --> Dec 2017 | Not yet recruiting --> Terminated | Trial primary completion date: Sep 2018 --> Oct 2017; Insufficient CO2 removal obtained with the PrismaLung membrane oxygenator Recruiting --> Completed | N=400 --> 736



	Diseases Companies Products Productz Mechanisms of Action Sites